Physician profile
Muhammad S Umer
NPI 1548237704
$8,094.94
in general payments reported to CMS, 2019-2025
32 companies · $1,741 in 2025
The $1,741 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $232 · 2021: $713 · 2022: $1,081 · 2023: $1,284 · 2024: $1,959 · 2025: $1,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,960 · Education: $24.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,960.01 |
| Education | $24.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,749.29 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $1,647.52 | 2019-2025 | Breztri, Farxiga |
| Amgen INC. | $1,280.45 | 2019-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,144.20 | 2019-2025 | Jardiance, Ofev, Tradjenta |
| Glaxosmithkline, LLC. | $293.90 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $222.80 | 2019-2024 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $220.02 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $212.22 | 2023-2025 | Diamondback Coronary, Freestyle Libre |
| Pfizer INC. | $206.33 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $198.47 | 2019-2022 | |
| Aurinia Pharma U.S., INC. | $123.66 | 2022 | |
| Janssen Pharmaceuticals, INC | $123.04 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $121.68 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $85.42 | 2019 | |
| Azurity Pharmaceuticals, INC. | $62.18 | 2023-2025 | Edarbi, Edarbi, Horizant |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $61.05 | 2023-2024 | Nuedexta |
| Mannkind Corporation | $42.85 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $41.64 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $32.89 | 2025 | |
| Amarin Pharma, INC. | $27.98 | 2021 | |
| Linus Health, INC. | $23.46 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.71 | 2021 | |
| Corcept Therapeutics | $17.45 | 2025 | Korlym |
| Ani Pharmaceuticals, INC. | $16.88 | 2024 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $16.87 | 2025 | Biktarvy |
| Currax Pharmaceuticals LLC | $16.76 | 2021 | |
| Esperion Therapeutics, INC. | $16.35 | 2025 | Nexletol |
| Sumitomo Pharma America, INC. | $14.75 | 2025 | Gemtesa |
| Seqirus USA INC | $14.57 | 2022 | |
| Genentech USA, INC. | $13.64 | 2022 | |
| Allergan, INC. | $12.87 | 2019 | |
| Astellas Pharma US INC | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Umer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.